Dietary Supplement & Cosmetics Legal Bulletin | February 2018

Shook, Hardy & Bacon L.L.P.

Shook, Hardy & Bacon L.L.P.


FDA Issues Draft Guidance for Homeopathic Drug Products

The U.S. Food and Drug Administration (FDA) has issued draft guidance, "Drug Products Labeled as Homeopathic," that would prioritize enforcement and regulatory actions to homeopathic products in several categories: (i) products with reported safety concerns; (ii) products that may contain ingredients associated with potentially significant safety concerns, such as pathogens, controlled substances or those with known toxicity; (iii) products administrated in a way other than oral or topical; (iv) products for prevention or treatment of serious or life-threatening diseases; (v) products for vulnerable populations, such as the elderly or immunocompromised; and (vi) products deemed adulterated under the federal Food, Drug, and Cosmetic Act. Public comments will be accepted until March 20, 2018.

“In many cases, people may be placing their trust and money in therapies that may bring little to no benefit to combating serious ailments, or worse—that may cause significant and even irreparable harm because the products are poorly manufactured, or contain active ingredients that aren’t adequately tested or disclosed to patients,” said FDA Commissioner Scott Gottlieb. “Our approach to regulating homeopathic drugs must evolve to reflect the current complexity of the market, by taking a more risk-based approach to enforcement. We respect that some individuals may want to use alternative treatments, but the FDA has a responsibility to protect the public from products that may not deliver any benefits and have the potential to cause harm.”


Rep. Calls for Rodan + Fields Investigation for Misleading Benzophenone Marketing

Rep. Frank Pallone Jr. (D-N.J.) has urged the U.S. Food and Drug Administration (FDA) to investigate Rodan + Fields after the cosmetics company allegedly used false and misleading marketing to deflect consumer inquiries about benzophenone, an ingredient that the California Environmental Protection Agency and World Health Organization’s International Agency for Research on Cancer have identified as a carcinogen and potential endocrine disruptor. In letters to FDA and Rodan + Fields, Pallone said that the company’s website contained links to more information “about the FDA’s position” on the chemical. One linked to California’s Safe Drinking Water and Toxic Enforcement Act website, but the other, Pallone said, directed consumers to a site “fully funded by the cosmetics industry itself and which outlines the industry’s self-assessment on the safety and use of benzophenone.” Pallone noted that the hyperlink has since been updated to link to FDA but does not guide consumers to any information about the agency’s position.


FDA Issues Warning Letters to Young Health Products, Optimum Bioenergy and Maine Natural Health

The U.S. Food and Drug Administration (FDA) has issued warning letters to the owners of Young Health Products LLC, Optimum Bioenergy International and Maine Natural Health Inc., notifying the companies of violations of the Federal Food, Drug and Cosmetic Act (FDCA) and the Current Good Manufacturing Practice (CGMP) regulations.

FDA reviewed the website of Young Health Products and determined that the claims the company makes for Lugol’s Solution 2%, Liquid Vitamin D3, Probimune, Flax Seed & Omega 3-6-9 Fish Oil, Balance Drops, Whey Protein and Fruit of the Spirit establish the products as drugs intended to treat a variety of diseases, including diabetes, high blood pressure, pain, inflammation and allergies. In addition, the company claims that its Flax Seed product can “help nourish the body when attacked by conditions” including cancer, Alzheimer’s, autism and asthma.

After inspecting Optimum Bioenergy International’s manufacturing facility in California, FDA warned the company that violations of agency regulations caused its dietary supplement products to be adulterated. Among the alleged violations were: (i) failure to establish procedures for quality control; (ii) failure to establish product specifications; (iii) failure to establish procedures for cleaning or pest control; and (iv) storage of components and finished products in tents outside the facility near potential sources of contamination.

FDA also warned the owner of Maine Natural Health that after a plant inspection and a review of its product labeling, multiple alleged violations of CGMP regulations and labeling requirements resulted in findings that the company was selling unapproved new drugs, adulterated and misbranded dietary supplements.


Claire's Pulls Cosmetics Products After Asbestos Allegedly Found

Claire's Stores Inc. has pulled from shelves several makeup products targeted at children after a CNN affiliate reported that a laboratory found asbestos in 24 talc-based items, including eye shadows and powder compacts. The company's initial tests reportedly showed no asbestos in the products, and it announced that it had confirmed the talc was obtained from a certified asbestos-free European supplier. Additional testing reportedly found the products are "asbestos free, completely safe and meet all government requirements." The North Carolina lab that apparently found the asbestos told CNN that Claire's had not tested the exact products that had tested positive because they remained at the lab.


Ad Board Reviews Claims for Memory Problems, Weight Loss and Teeth-Whitening

The National Advertising Division (NAD) has recommended that Cebria, the maker of Senior Moment Advance Memory Enhancing dietary supplements, discontinue claims that the product will alleviate memory problems or enhance memory function. Before the review, Cebria asked NAD to close the matter because the Federal Trade Commission previously reviewed the challenged claims and closed the investigation without taking action against the company. Cebria submitted evidence supporting its claims about the active ingredient but not the product as a whole, and NAD determined that the evidence was "not a good fit for the advertiser’s strong, unqualified claims.” NAD previously recommended that Cebria discontinue or modify “clinically proven” claims for Procera AVH supplements, although the advertiser had conducted a “peer-reviewed, double-blind, randomized, placebo-controlled clinical trial” on the supplement. 

The Electronic Retailing Self-Regulation Program (ERSP) reviewed online advertising for Mayfair’s Garcinia Cambogia Allure weight-loss product. After reviewing outlines and summaries of studies, ERSP determined Mayfair’s claims were not supported by the evidence provided. Mayfair has notified ERSP that it will no longer sell Garcinia Cambogia Allure or any other garcinia cambogia supplement. ERSP also reviewed Stain-Away LLC's Power Swabs marketing claims and determined that Stain-Away supported its claims that the product whitens teeth by an average of six shades in seven days and that users will see visible results within five minutes of use.



Court Trims Class Claims from NBTY Labeling Action

An Illinois federal court has dismissed nationwide class claims alleging NBTY Inc. misrepresents the health benefits of glutamine in its marketing for Body Fortress 100% Pure Glutamine Powder. DeBernardis v. NBTY Inc., No. 17-6125 (N.D. Ill., entered January 18, 2018). The court determined the issue of personal jurisdiction with regard to the U.S. Supreme Court's 2017 decision in Bristol-Myers Squibb v. Superior Court of California, San Francisco County, which confirmed that courts have limited jurisdiction over non-resident defendants.

The Illinois court concluded that “it is more likely than not based on the Supreme Court’s comments about federalism that the courts will apply Bristol-Myers Squibb to outlaw nationwide class actions in a for[u]m, such as in this case, where there is no general jurisdiction over the Defendants.” Accordingly, the court dismissed putative class claims extending outside of Illinois. Further, the plaintiff failed to allege a potential future injury, the court held, so he lacked standing to seek an injunction.


FTC and Supplement Maker Settle Claims on Products Targeting Cancer Patients

CellMark Biopharma LLC has agreed to stop making false, misleading or unsubstantiated claims about CellAssure and Cognify, supplements marketed to cancer patients. Fed. Trade Comm’n v. CellMark Biopharma LLC, No. 18-14 (M.D. Fla., entered January 11, 2018). The Federal Trade Commission's complaint alleged that CellMark advertised its products as able to treat or mitigate cachexia, cognitive dysfunction, cancer and the effects of cancer treatment. CellMark is barred from making any representation about any product marketed to treat any disease without substantiating scientific evidence. The company is also enjoined from “disclosing, using or benefitting from” any personal customer data obtained before the entry of the consent order. According to the order, CellMark CEO Derek Vest entered federal prison in August 2017 to serve an 18-month sentence in an unrelated case involving the marketing of dietary supplements.


Court Denies Hain Celestial’s Motion to Dismiss “Natural” Deodorant Class Action

A California federal court has denied Hain Celestial Group’s motion to dismiss a putative class action alleging that its Jason deodorant products are advertised and labeled as “natural” despite containing tocopheryl acetate, glycerin and ethylhexylglycerin. Pecanha v. The Hain Celestial Grp., No. 17-4517 (N.D. Cal., entered January 24, 2018). Additional details about the matter appear in Issue 53 of this Bulletin.

The court first refused to dismiss the complaint’s fraud, breach of warranty and unjust enrichment claims, finding they involved questions of fact that could not be resolved at this stage of litigation. The court also refused to grant a stay, finding no evidence that the U.S. Food and Drug Administration is defining "natural" in cosmetics. In addition, the court rejected Hain’s argument that its subsidiary manufactured, sold and marketed Jason products and that the plaintiffs had alleged no wrongdoing by Hain itself.


Plaintiff Alleges Whole Foods Vitamin B12 Supplements Have Too Much Vitamin B12

A California plaintiff has filed a putative class action alleging that some of Whole Foods Market's liquid vitamin B12 supplements contain amounts of the vitamin in “significant excess” of the 500 to 1,000 micrograms advertised on the product labels. Palmer v. Whole Foods Market IP, L.P., No. BC690514 (Cal. Super. Ct., Los Angeles Cty., filed January 18, 2018). The plaintiff alleges that the products he purchased—Liquid Vitamin B12, Super B12 B Complex and Liquid Energy Shot—as well as similar B vitamin products made with cyanocobalamin contain amounts of the vitamin in excess of the amount a reasonable consumer would expect. The plaintiff speculates that because cyanocobalamin is less stable than other forms of the vitamin, Whole Foods may have added the excess to ensure that consumers received the vitamin even as the product degraded after opening or that the excess is “indicative of a lack of quality control.” The complaint also alleges that the labeling is false and misleading even if it complies with the requirements of the Federal Food, Drug and Cosmetic Act, which allegedly “does not provide a shield from liability.”


Plaintiff Alleges Protein Supplement Container Is More Than Half Slack Fill

A plaintiff has filed a putative class action alleging Coexist Nutrition's 14.82-ounce containers of 22 Days Nutrition Plant Power Protein Supplement contain as much as 56 percent slack fill. Ross v. Coexist Nutrition, LLC, No. 18-0587 (S.D.N.Y., filed January 23, 2018). The plaintiff asserts that Coexist cannot argue that the slack fill is functional because a smaller container of another Coexist product, 22 Days Organic Plant Protein Powder, contains 46 percent slack fill. Claiming deceptive and unfair trade practices, false advertising and common law fraud, the plaintiff seeks injunctive relief, class certification, restitution, disgorgement, reimbursement, damages and attorney’s fees.


Peter Thomas Roth Eye Serum Caused Permanent Injury, Lawsuit Alleges

A plaintiff has filed a lawsuit alleging Peter Thomas Roth Labs' eye serum, which he purchased through co-defendant Sephora, caused permanent injuries to his face. Grullon v. Peter Thomas Roth Labs LLC, No. 150399/2018 (N.Y. Super. Ct., filed January 15, 2018). The complaint alleges that the plaintiff used Peter Thomas Roth Laser Free Eye Serum according to instructions, but after three uses, red and painful bumps developed where the product was applied. The plaintiff further alleges that one of the bumps developed a hole which remains unhealed. Claiming that both companies knew the serum was “defective and dangerous” and that both defendants are “guilty of malice, oppression and fraud,” the plaintiff seeks $500,000 in damages from each defendant for injury, physical and mental pain, anguish and distress.


Banana Boat Lawsuits Allege Label Misrepresentation

A consumer has filed a putative class action alleging Edgewell Personal Care's Banana Boat line of sunscreens is not "natural" as marketed because the products contain synthetic and artificial ingredients. Hernandez v. Edgewell Personal Care, LLC, No. 18-128 (C.D. Cal., filed January 21, 2018). The plaintiff asserts that Natural Reflect, Natural Reflect Baby and Natural Reflect Kids contain several artificial ingredients, including glyceryl stearate, tocopheryl acetate, dimethicone and phenoxyethanol.

In another Edgewell lawsuit, a consumer has alleged that Banana Boat Kids products were labeled as SPF 50 but offered SPF 8 protection. The case has been referred for settlement mediation. In re Edgewell Personal Care Co. Litig., No. 16-3371 (E.D.N.Y., entered January 23, 2018).

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Shook, Hardy & Bacon L.L.P. | Attorney Advertising

Written by:

Shook, Hardy & Bacon L.L.P.

Shook, Hardy & Bacon L.L.P. on:

Readers' Choice 2017
Reporters on Deadline

Related Case Law

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.